- Spanish PM says Musk 'stirs up hatred', warns against fascism
- Bournemouth striker Unal tears ACL in training session
- US private sector hiring undershoots expectations: ADP
- Arteta mocked by League Cup organisers after 'tricky' ball excuse
- US tariffs unlikely to have 'significant' inflation impact: Fed official
- Debris falling from the sky: more often, more risk
- Lebanon leaders in talks for new bid to elect president
- Antarctic sea ice rebounds from record lows: US scientists
- Can EU stand up to belligerent Big Tech in new Trump era?
- France goalkeeper Samba joins Rennes
- Global stocks diverge on renewed US inflation fears
- France coach Deschamps to step down after 2026 World Cup
- French magazine run by autistic journalists hits newsstands
- US, Canadian and Australian travellers now face UK entry fee
- France urges European Commission to be firm against Musk interference
- Wildfire sparks panicked evacuations in Los Angeles suburbs
- Nobel winner Ressa tells AFP 'dangerous times' ahead after Meta ends US fact-checking
- Indonesia upholds iPhone 16 sales ban after Apple offers $1 bn investment
- Dutch great Kluivert named Indonesia coach in hunt for World Cup spot
- UK's Catherine turns 43 hoping for better year
- France coach Deschamps says will leave after 2026 World Cup
- South Syria fighters reluctant to give up weapons: spokesman
- Dutch great Kluivert named coach of Indonesia
- New Zealand crush Sri Lanka by 113 runs in 2nd ODI to win series
- West Ham cancel Lopetegui press conference as sacking rumours swirl
- Questions remain over South African involvement in Champions Cup
- OpenAI chief Sam Altman denies sister's sexual abuse accusations
- Hundreds rally for South Korea's Yoon as new arrest bid beckons
- Bangladesh orders banks to assist UK minister graft probe
- Germans turn to balcony solar panels to save money
- Theekshana hat-trick restricts NZ to 255-9 in 2nd Sri Lanka ODI
- Young's buzzer-beater lifts Hawks, Celtics down Nuggets
- Grief and nostalgia in India's 'Jimmy Carter village'
- Venezuela's 'colectivos' ready to pounce as opposition plans protest
- Thai police hunt suspect over Cambodian politician shooting
- Venezuela on tenterhooks ahead of rival protests, Maduro swearing-in
- Devajit Saikia: lawyer, modest player and next India cricket chief
- S. Korea's impeached President Yoon holds out in capital 'fortress'
- Samsung warns fourth-quarter profit to miss forecasts
- China's viral wild boar hunters attract fame and concern
- Forgotten but not gone: Covid keeps killing, five years on
- Is the world ready for the next pandemic?
- Trump's provocative, often confusing, US foreign policy is back
- Rescuers search for survivors after quake in China's Tibet kills at least 126
- Brazil gears up for first climate conference in Amazon
- In Brazil, an Amazon reforestation project seeks to redeem carbon markets
- Djokovic with point to prove against younger rivals at Australian Open
- Asian markets mixed after Wall St hit by US inflation fears
- Mexicans offered $1,300 to hand in a machine gun
- Venezuela arrests two Americans, five other 'mercenaries'
RIO | -0.45% | 57.93 | $ | |
BCC | -1.13% | 116.895 | $ | |
JRI | -0.1% | 12.208 | $ | |
SCS | -0.54% | 11.14 | $ | |
BTI | -1.02% | 36.41 | $ | |
CMSD | -0.56% | 23.33 | $ | |
CMSC | -0.3% | 23.16 | $ | |
BCE | -2.05% | 23.38 | $ | |
NGG | -2.41% | 57.22 | $ | |
RELX | 0.79% | 46.345 | $ | |
RYCEF | -0.42% | 7.17 | $ | |
GSK | -2% | 33.42 | $ | |
RBGPF | -4.54% | 59.31 | $ | |
BP | -2.25% | 31.13 | $ | |
VOD | -3.25% | 8.145 | $ | |
AZN | -1.35% | 65.75 | $ |
French inventor of abortion pill calls Wyoming ban 'scandalous'
French scientist Etienne-Emile Baulieu, known as the father of the abortion pill, said it was "scandalous" and "a setback for women's freedom" that the US state of Wyoming has banned the drug.
Baulieu, who at the age of 96 is still working on treatments for depression and Alzheimer's, did not mince his words about the ban.
"It is a setback for women's freedom, particularly for those in the most precarious position who do not have the means to go to another state" to get an abortion, he told AFP in an interview.
Last week Wyoming became the first US state to outlaw the use of the abortion pill.
It was the latest point marked for conservative anti-abortion activists in the United States after the Supreme Court overturned the constitutional right to the procedure last year, leaving the policy to individual states.
Baulieu said he had dedicated a large part of his life to "increasing the freedom of women," and the ban was a step in the opposite direction.
Born in Strasbourg in 1926 to Jewish parents, Baulieu was raised by his feminist mother after his father, a doctor, died when he was a boy. At the age of 15, Baulieu joined the French resistance against Nazi occupation.
He went on to become a self-described "doctor who does science," specialising in the field of steroid hormones.
Invited to work in the United States, Baulieu was noticed in 1961 by Gregory Pincus, known as the father of the contraceptive pill, who convinced him to focus on sex hormones.
Back in France, Baulieu designed a way to block the effect of the hormone progesterone, which is essential for the egg to implant in the uterus after fertilisation.
"I wanted to make a contragestive," which stops gestation, he told AFP.
Partnering with the French Roussel-Uclaf laboratory, the oral drug RU-486, also known as mifepristone, was developed in 1982, providing a safe and inexpensive alternative to surgical abortion.
But there was a long battle for the drug to become authorised in the United States, where anti-abortion activists dubbed it the "death pill".
- 'Fanaticism and ignorance' -
In early March, French President Emmanuel Macron praised Baulieu's resilience when he presented the scientist with the Grand-Croix de la Legion d'Honneur, the top rank in France's honours system.
"You, a Jew and a resistance fighter, you were overwhelmed with the most atrocious insults and even compared to Nazi scientists," Macron said.
"But you held on, for the love of freedom and science."
Baulieu's wife Simone Harari Baulieu, a media producer in France, said "adversity slides off him like water off a duck's back".
She added that the recent "step backwards" in the United States was propelled by "fanaticism and ignorance".
Even at age 96, Baulieu heads into his office at the Kremlin-Bicetre University Hospital in the southern suburbs of Paris three times a week.
Stacks of photos, diplomas and binders contain "the work of a lifetime," the scientist said, adding that he still wants to "be useful".
His latest award is pinned to his blue suit, but Baulieu said he "never seriously hoped to receive such honours".
"It was a pleasure, but what interests me is improving people's health."
- 'Driving force' -
The team in his lab are continuing research he began years ago aiming to prevent the development of Alzheimer's disease, as well as treatment for severe depression, for which clinical trials begin in the coming months.
Baulieu said "there is no reason we cannot find treatments" for both illnesses, which have stubbornly evaded many previous attempts.
Julien Giustiniani, the team leader at the Baulieu Institute, which was created to finance research into dementia, said Baulieu was "always enthusiastic".
"He is a driving force for us," Giustiniani said.
Though Baulieu now uses a cane to walk, he exudes a tireless energy.
He partly credits using DHEA, a natural hormone produced by the adrenal gland, which Baulieu first described in the 1960s and has been touted as an anti-ageing supplement.
The causes that have dominated his life were "women, brain health and longevity," Baulieu said.
"I would be bored if I did not work anymore," he added.
X.Karnes--AMWN